Did Transformational Leadership Play a Role in Changing the Overall Performance ofa Major US Corporation?

Abstract

Prior work has discussed how Pfizer in partnership with BioNTech developed and produced the mRNA vaccine in record time to ward off the deadly Covid virus (Bourla, 2021). The Chief Executive Officer (CEO) of Pfizer played a valiant role in motivating the workforce of Pfizer to achieve this milestone in a very short period. However, no study in the past has evaluated the traits of a transformational leader as exhibited by the CEO of this company during the Covid-19 virus crisis period and beyond. Further, no prior work has documented whether the financial wellbeing of Pfizer has improved under the current CEO’s leadership. This paper aims to close this gap in the knowledge base. This work shows that although the current CEO exhibited some of the pertinent traits of a successful transformational leader, the financial condition of the company has only improved somewhat under his leadership.